Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 31-40 of 42 for multiple myeloma

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Patients With Multiple Myeloma That is Resistant to Current Standard of Care Treatments

    Rochester, MN

  2. A Study to Investigate the Safety and Efficacy of SAR446523 Injected Subcutaneously in Adult Participants With Relapsed/Refractory Myeloma

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  3. Solitary Bone Plasmacytomas to Elucidate Their Pathogenesis and Risk of Progression to Multiple Myeloma

    Rochester, MN

  4. American Society of Hematology Research Collaborative’s Data Hub Multiple Myeloma Program

    Rochester, MN

  5. The Impact of a Geriatric Assessment in Elderly Patients with Multiple Myeloma

    Rochester, MN

  6. A study of how current treatments impact the course of relapsed myeloma and the effect of the treatments on the quality-of-life measurements.

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  7. MMRC Horizon One Adaptive Platform Trial Evaluating Therapies In RRMM

    Rochester, MN

  8. Global Cardio Oncology Registry

    Rochester, MN

  9. Impact of Restricted Medication Access on Care of Multiple Myeloma Patients

    Rochester, MN

  10. cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease (CAMPERR)

    Rochester, MN

.

Mayo Clinic Footer